| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
45,436,000 | 34,639,000 | 25,785,000 | 22,680,000 | 23,601,000 |
| Cost of Revenue
|
-21,030,000 | -17,487,000 | -13,060,000 | -12,220,000 | -12,998,000 |
|
Gross Profit
|
24,406,000 | 17,152,000 | 12,725,000 | 10,460,000 | 10,603,000 |
|
Selling, General and Administrative Expenses
|
-5,150,000 | -4,144,000 | -2,735,000 | -2,318,000 | -2,336,000 |
|
Research and Development Expenses
|
-10,058,000 | -8,091,000 | -6,456,000 | -5,872,000 | -5,005,000 |
| Depreciation, Amortization and Depletion
|
-1,148,000 | -1,223,000 | -1,448,000 | -1,869,000 | -2,100,000 |
| Other Income/Expense, Operating
|
48,000 | -- | 48,000 | 34,000 | 102,000 |
|
Operating Income/Expenses
|
-16,356,000 | -13,458,000 | -10,639,000 | -10,059,000 | -9,339,000 |
|
Total Operating Profit/Loss
|
8,050,000 | 3,694,000 | 2,086,000 | 401,000 | 1,264,000 |
| Total Net Finance Income/Expense
|
43,000 | 84,000 | 90,000 | 100,000 | -23,000 |
| Net Investment Income
|
366,000 | 366,000 | -2,000 | 1,000 | -62,000 |
| Irregular Income/Expenses
|
0 | 0 | -186,000 | 0 | 0 |
|
Other Income/Expense, Non-Operating
|
-362,000 | -4,000 | 1,000 | -10,000 | 5,000 |
|
Non-Operating Income/Expenses, Total
|
47,000 | 446,000 | -97,000 | 91,000 | -80,000 |
|
Pretax Income
|
8,097,000 | 4,140,000 | 1,989,000 | 492,000 | 1,184,000 |
|
Provision for Income Tax
|
-390,000 | 103,000 | -381,000 | 346,000 | 122,000 |
|
Earnings from Equity Interest, Post-Tax
|
18,000 | 26,000 | 33,000 | 16,000 | 14,000 |
|
Net Income from Continuing Operations
|
7,725,000 | 4,269,000 | 1,641,000 | 854,000 | 1,320,000 |
|
Discontinued Operations
|
-106,000 | 66,000 | 0 | 0 | -- |
|
Net Income after Extraordinary Items and Discontinued Operations
|
7,619,000 | 4,335,000 | 1,641,000 | 854,000 | 1,320,000 |
|
Net Income after Non-Controlling/Minority Interests
|
7,619,000 | 4,335,000 | 1,641,000 | 854,000 | 1,320,000 |
|
Net Income Available to Common Stockholders
|
7,619,000 | 4,335,000 | 1,641,000 | 854,000 | 1,320,000 |
|
Dilution to Earnings
|
-- | -- | -- | -- | 0 |
|
Diluted Net Income Available to Common Stockholders
|
7,619,000 | 4,335,000 | 1,641,000 | 854,000 | 1,320,000 |
| Basic EPS
|
4.67 | 2.67 | 1.01 | 0.53 | 0.85 |
| Diluted EPS
|
4.61 | 2.65 | 1.00 | 0.53 | 0.84 |
|
Basic Weighted Average Shares Outstanding
|
1,631,500 | 1,624,000 | 1,620,000 | 1,614,000 | 1,561,000 |
|
Diluted Weighted Average Shares Outstanding
|
1,654,750 | 1,636,000 | 1,637,000 | 1,625,000 | 1,571,000 |
|
Reported Normalized Diluted EPS
|
4.58 | 4.17 | 3.31 | 2.65 | 3.50 |
| Income Statement, Supplemental
|
12/31/2022 - 12/28/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade